Rolf Teschke | Medicine and Dentistry | Best Paper Award

Posted on by Phenomenological Research Awards

Prof. Rolf Teschke | Medicine and Dentistry | Best Paper Award

Professor at Klinikum Hanau | Germany

Prof. Rolf Teschke is an internationally recognized expert in hepatology whose distinguished career has significantly influenced contemporary understanding of liver diseases, hepatotoxicity, and drug-induced liver injury. Educated at leading medical institutions and trained in internal medicine with specialization in gastroenterology and hepatology, he advanced early in his career through rigorous scientific and clinical environments that shaped his enduring interest in hepatic metabolism and toxicology. His research journey includes extensive work in experimental hepatology, where he contributed pivotal insights into microsomal ethanol-oxidizing systems, cytochrome P450 related pathways, and the biochemical mechanisms underlying alcohol-associated and toxin-induced liver damage. Over several decades, Prof. Rolf Teschke has held prominent academic and clinical positions, leading major medical departments and contributing to both patient care and research innovation. His expertise is particularly well known for advancing causality assessment methodologies in drug-induced liver injury, especially through his influential work with the RUCAM system, which has become a globally referenced tool in hepatotoxicity evaluation. Throughout his career, he has produced a substantial body of peer-reviewed literature, reflecting profound scientific productivity and impact. His publication record includes 171 documents, supported by 6,888 citations across 4,040 citing documents, and an impressive h-index of 48, underscoring the depth, relevance, and international recognition of his work. Prof. Rolf Teschke’s research interests span alcoholic liver disease, herbal and drug hepatotoxicity, biochemical enzymology, and clinical hepatology, integrating laboratory discoveries with real-world clinical applications to improve diagnostic standards and therapeutic strategies. He has authored and co-authored more than 250 publications, including articles, book chapters, and comprehensive reviews, contributing to foundational knowledge used by clinicians, toxicologists, and regulatory bodies worldwide. In addition to research, he has served in editorial roles for several journals, helping guide scientific discourse in hepatology and liver toxicology. Overall, Prof. Rolf Teschke’s career reflects a sustained commitment to advancing scientific excellence, improving patient outcomes, and shaping global best practices in the study of liver injury, marking him as one of the leading contributors to modern hepatology.

Profile; Scopus | Orcid

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Teschke, R. Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types. Review.
Annotation: Introduces a new five-type classification system for liver injury associated with severe immune-mediated skin reactions.

Teschke, R. Acute Liver Failure Due to Assumed Drug Induced Liver Injury but Lack of Any Validated Causality Algorithm: Evidence by 36 Cohort Reports with 21,709 Cases. Review.
Annotation: Critically analyzes large cohorts revealing gaps in validated causality assessment for assumed DILI-related acute liver failure.

Teschke, R. Idiosyncratic Hepatocellular Drug-Induced Liver Injury by Flucloxacillin with Evidence Based on RUCAM and HLA B57:01 Genotype.* Review.
Annotation: Examines metabolic and immune mechanisms underlying flucloxacillin-induced hepatocellular injury.

Teschke, R., et al. Successful Corticosteroid Therapy for Severe Liver Injury Secondary to Herbal Traditional Chinese Medicine Mega Defends X: A Case Report. Article, 2024.
Annotation: Documents a clinically significant case showing steroid responsiveness in herb-induced liver injury assessed by updated RUCAM.

Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award 

Assistant professor at Beth Israel Deaconess Medical Center | United States

Dr. Zsuzsanna Zsengeller is a distinguished medical scientist whose career spans clinical medicine, molecular biology, and translational research. She has established herself as a global leader in the investigation of preeclampsia, mitochondrial dysfunction, and kidney-related disorders. With appointments at world-renowned institutions, she has advanced knowledge in gene therapy, molecular signaling, and maternal-fetal health. Her professional journey demonstrates a seamless integration of clinical insight and laboratory research, producing innovative therapeutic approaches. Through consistent scholarly output, grant leadership, and mentorship of future scientists, Dr. Zsuzsanna Zsengeller embodies excellence in academic medicine and translational science, with her work directly impacting patient health worldwide.

Profile:

Orcid

Education:

Dr. Zsuzsanna Zsengeller earned her Doctor of Medicine degree in General Medicine, followed by a Ph.D. in Medical Science with a strong foundation in microbiology. Her academic path was marked by a commitment to understanding complex disease mechanisms through both experimental and clinical approaches. Her postgraduate training included prestigious postdoctoral fellowships in pulmonary biology and respiratory diseases, where she refined her expertise in molecular and cellular biology. These academic experiences provided the groundwork for her lifelong research into oxidative stress, immune signaling, and vascular biology, ultimately shaping her into a well-recognized expert in mitochondrial and maternal health research.

Experience:

Dr. Zsuzsanna Zsengeller has extensive experience as both a clinician and scientist, having held positions across leading hospitals, research institutions, and industry collaborations. Her work includes significant contributions to pulmonary biology, renal pathology, and preeclampsia research. She has served in roles as staff scientist, senior scientist, consultant, and academic faculty member, currently serving as Assistant Professor of Medicine at Harvard Medical School. Her collaborations with multidisciplinary teams have resulted in advancements in therapeutic strategies for cardiovascular, renal, and maternal health. With experience in academia, industry, and clinical translation, she has built a unique career that bridges discovery and application.

Research Interest:

Dr. Zsuzsanna Zsengeller’s research interests center on the pathogenesis and treatment of preeclampsia, kidney disease, and mitochondrial dysfunction. She investigates redox biology, nitric oxide modulation, and oxidative stress pathways to understand how cellular signaling impacts maternal and fetal outcomes. Her translational studies have examined novel dual-function redox modulators, antioxidants, and mitochondrial-targeted therapies. Beyond maternal health, her work extends into nephrology and cardiovascular disease, with particular focus on mechanisms of APOL nephropathy and endothelial dysfunction. Through advanced molecular techniques and therapeutic modeling, her research seeks to translate laboratory discoveries into clinical strategies, offering hope for improved patient outcomes worldwide.

Awards and Honors:

Dr. Zsuzsanna Zsengeller has been recognized with numerous honors that reflect her leadership in biomedical science and translational medicine. She has received institutional research funding awards, including competitive support for her pioneering work on mitochondrial-targeted antioxidants for preeclampsia therapy. Her contributions have also been acknowledged through awards from scientific societies, highlighting her excellence in poster presentations, mentorship, and innovative project design. Her research projects have consistently received funding from federal agencies and medical foundations, underscoring the clinical relevance and impact of her work. These awards honor her as a trailblazer in developing therapies addressing urgent global health challenges.

Publications:

Title: Development of Diaryl Hydrazones for Alleviation of Mitochondrial Oxidative Stress in Preeclampsia
Year of Publication: 2025
Citation: 1

Title: Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF
Year of Publication: 2025
Citation: 1

Title: A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 Inhibition
Year of Publication: 2025
Citation: 5

Title: Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2
Year of Publication: 2024
Citation: 5

Title: Solvent- and Catalyst-Free Environmentally Benign High Hydrostatic Pressure-Assisted Synthesis of Bioactive Hydrazones and the Evaluation of Their Stability Under Various Storage Conditions
Year of Publication: 2024
Citation: 3

Title: A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia—A Proof-of-Principle Study in a Murine Model
Year of Publication: 2023
Citation: 3

Title: Hepatocyte nuclear factor 4α mediated quinolinate phosphoribosylltransferase (QPRT) expression in the kidney facilitates resilience against acute kidney injury
Year of Publication: 2023
Citation: 8

Conclusion:

Dr. Zsuzsanna  Zsengeller stands as a pioneering physician-scientist whose research has transformed the understanding of oxidative stress, mitochondrial dysfunction, and maternal-fetal disorders. Her leadership in translational medicine continues to advance new therapies that address major public health burdens, particularly preeclampsia and kidney disease. Through groundbreaking research, impactful publications, and mentorship of future leaders, she exemplifies the highest standards of academic and clinical excellence. Her career demonstrates how dedication to discovery can be translated into real-world medical advancements, making her a highly deserving candidate for prestigious recognition in biomedical and clinical research innovation.

Sandhini Agarwal | Medicine | Best Researcher Award

Posted on by Phenomenological Research Awards

Ms. Sandhini Agarwal | Medicine | Best Researcher Award

Medical Student at Valley Vein Health Center, Georgetown University School of Medicine, United States.

🌍Sandhini Agarwal is a medical student at Georgetown University, with extensive experience in clinical settings, research, and leadership. She has worked as a research assistant at UChicago Medicine and Stanford Medicine, focusing on neural network-based systems, pediatric cardiology, and thyroid cancer. Her clinical experience spans pediatrics, ambulatory care, and community health outreach. Additionally, she has held leadership roles in organizations such as Georgetown Street Medicine and the Phoenix Biology RSO at UChicago. She has also been an active volunteer with Street Life Ministries and has received numerous academic awards.

Profile👤

Education 🎓

🎓Sandhini Agarwal attended the University of Chicago, where she earned a B.S. in Biological Sciences and a minor in Health and Society, graduating cum laude with a GPA of 3.88/4.0. During her time at UChicago, she was consistently recognized for her academic excellence, making the Dean’s List from 2021 to 2022 and earning the Clinical Excellence Scholars Track recognition. She also received multiple awards during high school, including the Senior Book Award in Biology and the Faculty Cup Nominee. Sandhini is currently pursuing her medical degree at Georgetown University School of Medicine, Class of 2028. Her academic focus continues to center around biology, medicine, and public health, with a particular interest in addressing health disparities and improving healthcare access for underserved communities. Sandhini’s academic achievements reflect her commitment to excellence and her determination to make a meaningful impact in the medical field.

Experience💼

🩺Sandhini Agarwal has extensive clinical and research experience that spans multiple prestigious institutions. She is currently involved in clinical work at Georgetown Med, including shadowing Dr. Sejal Bavishi in pediatric outpatient clinics and assisting with physical exams. She also plays a key role in community health initiatives through Hoya Clinic and Learn2Derm, where she educates underserved children on skincare. Prior to Georgetown, Sandhini gained valuable experience at UChicago Medicine, conducting patient interviews as a research assistant for the Hospitalist Project. She also worked at Valley Vein Health Center as a patient care coordinator, conducting surveys and researching Ozempic’s impact on lymphedema. In addition to her clinical roles, Sandhini has participated in research at institutions such as Stanford, where she worked on developing neural network-based systems for medical imaging, and at Harvard Medicine, where she researched thyroid cancer pathways. Her experiences in both clinical care and research have provided her with a comprehensive understanding of healthcare.👨‍🔬🌍

Awards and Honors 🏆

Sandhini Agarwal has received several prestigious awards for her academic and extracurricular achievements. At the University of Chicago, she earned a spot on the Dean’s List from 2021 to 2022 and participated in the Clinical Excellence Scholars Track, recognizing her academic prowess and commitment to clinical excellence. In high school, she received multiple honors, including the Senior Book Award in Biology and the Faculty Cup Nominee. Sandhini was also recognized as a National AP Scholar for her high AP scores and received the Katen Metcalf Scholar award in 2021. She was honored with the Aspirations Award by the National Center for Women & Information Technology in 2018 and won several medals in the National Spanish Exam, including Gold in 2017. Sandhini’s accomplishments reflect her strong academic background and her commitment to leadership, service, and excellence in healthcare.

Research Interests 🔬

🔬Sandhini Agarwal’s research focuses on the intersection of biology, medicine, and technology, with a particular interest in pediatric cardiology, endocrinology, and neuroimaging. At UChicago Medicine, she researched FoxF1 expression in the second heart field and its role in cardiomyocyte differentiation and heart development. This work contributed to the understanding of heart disease and its underlying mechanisms. She also worked on analyzing thyroid cancer pathways at Harvard Medicine, focusing on the diagnosis-to-treatment process for thyroid cancer patients. Sandhini’s research experience extends to neural networks for medical imaging at Stanford, where she developed a system to segment brain parenchymal metastatic lesions using radiological data. In addition, she contributed to cardiovascular drug discovery at UChicago, analyzing genomic data and supporting the HeartBioPortal database. Sandhini’s research aims to enhance healthcare delivery and outcomes, with a particular focus on improving diagnostic accuracy, treatment pathways, and patient care, especially in underserved populations.🌿🧪

Conclusion 🔚 

Sandhini Agarwal is highly deserving of the Best Researcher Award. Her dedication to both research and clinical practice, combined with her leadership in social initiatives, demonstrates a holistic approach to the field of medicine. Her achievements indicate a future leader in healthcare and research, and her continued contributions promise even greater impacts in the years to come.

Publications Top Notes 📚

A Holistic Approach to Undesired Content Detection in the Real World

Authors: Markov, T., Zhang, C., Agarwal, S., Jiang, A., Weng, L.

Citations: 35

Year: 2023

Training language models to follow instructions with human feedback

Authors: Ouyang, L., Wu, J., Jiang, X., Leike, J., Lowe, R.

Citations: 3,339

Year: 2022

Learning Transferable Visual Models From Natural Language Supervision

Authors: Radford, A., Kim, J.W., Hallacy, C., Krueger, G., Sutskever, I.

Citations: 9,325

Year: 2021

Language models are few-shot learners

Authors: Brown, T.B., Mann, B., Ryder, N., Sutskever, I., Amodei, D.

Citations: 15,410

Year: 2020

Recursive routing networks: Learning to compose modules for language understanding

Authors: Cases, I., Rosenbaum, C., Riemer, M., Potts, C., Karttunen, L.

Citations: 11

Year: 2019